 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
2. Ferrannini E, Mari A: How to measure insulin sensitivity. J Hypertens 1998, 16:895–906. 3. Iozzo P, Beck-Nielsen H, Laakso M, et al.: Independent influence of age on basal insulin secretion in nondiabetic humans. J Clin Endocrinol Metab 1999, 84:863–868. 4. DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of insulin-independent and insulin-dependent diabetes. Diabetologia 1982, 23:313–320. 5. DeFronzo RA, Ferrannini E, Hendler R, et al.: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983, 32:35–45. 6. Landau BR,Wahren J, Chandramouli V, et al.: Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest 1995, 95:172–178. 7. Gastaldelli A, Baldi S, Pettiti M, et al.: Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in hormones. Diabetes 2000, 49:1367–1373. 8. Paternostro G, Camici PG, Lammerstma AA, et al.: Cardiac and skeletal muscle insulin resistance in patients with coronary artery disease: a study with positron-emitting tomography. J Clin Invest 1996, 98:2094–2099. 9. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ: Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993, 92:91–98. 10. Groop LC, Saloranta C, Schenk M, et al.: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non–insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991, 72:96–102. 11. Ferrannini E, Camastra S, Coppack SW, et al.: Insulin action and non-esterified fatty acids. Proc Nutr Soc 1997, 56:753–761. 12. Randle PJ, Garland PB, Hales CN, Newsholme EA:The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, i:785–789. 13. Golay A, Swilocky AL, Chen YD, Reaven GM: Relationship between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non–insulin-dependent diabetic individuals. Metabolism 1987, 36:692–696. 14. Bonadonna RC, Saccomani MP, Seely L, et al.: Glucose transport in human skeletal muscle: the in vivo response to insulin. Diabetes 1993, 42:191–198. 15. Bonadonna RC, Del Prato S, Cobelli C, et al.: Transmembrane glucose transport in skeletal muscle of patients with non–insulin-dependent diabetes. J Clin Invest 1993, 92:486–492. 16. Camastra S, Bonora E, Del Prato S, et al.: Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord 1999, 23(12):1307–1313. 17. Ferrannini E,Vichi S, Beck-Nielsen H, et al.: Insulin action and age. Diabetes 1996, 45:947–953. 18. Ferrannini E, Natali A, Bell P, et al.: Insulin resistance and hypersecretion in obesity. J Clin Invest 1997, 100:1166–1173. 19. Greco AV, Mingrone G, Giancaterini A, et al.: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002, 51(1):144–151. 20. Ferrannini E, Natali A, Capaldo B, et al.: Insulin resistance, hyperinsuline-mia, and blood pressure. Role of age and obesity. Hypertension 1997, 30:1144–1149. 21. Yki-Järvinen H, Utriainen T: Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998, 41:369–379. 22. Taddei S,Virdis A, Mattei P, et al.: Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hyper-tension. Circulation 1995, 92:2911–2920. 23. Steinberg HO, Brechtel G, Johson A, et al.: Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994, 94:1172–1179. 24. Tack CJ, Lutterman JA,Vervoot G, et al.: Activation of the sodium-potassium pump contributes to insulin-induced vasodilatation in humans. Hypertension 1996, 28:426–432. 25. Muscelli E, Emdin M, Natali A, et al.: Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 1998, 83:2084–2090. 26. Gastaldelli A, Emdin M, Conforti F, et al.: Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol 2000, 279(6):R2022–R2025. 27. Schwartz MW, Figlewicz DP, Baskin DB, et al.: Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992, 13:81–113.
|